Tekla Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.42M Hold
2023
Q1
$1.64M Hold
2022
Q4
$2.2M Hold
2022
Q3
$2.85M Hold
2022
Q2
$3.17M Buy
2022
Q1
$2.54M Hold
2021
Q4
$2.73M Hold
2021
Q3
$3.15M Hold
2021
Q2
$3.59M Hold
2021
Q1
$3.81M Buy